AAM Welcomes CMS Tiers Rule For Generics

Follows Industry Criticism Of Generics Increasingly Being Placed On Higher-Cost Tiers

A proposed rule set out by the US Centers for Medicare & Medicaid Services directing that generics should be covered on generic tiers has been commended by local off-patent industry group the US Association for Accessible Medicines.

CMS logo on phone
The CMS’ proposed rule has been applauded by the AAM (Shutterstock)

A proposed rule published by the US Centers for Medicare & Medicaid Services requiring generic drugs to be covered on generic tiers has been applauded by local generics and biosimilars industry body the Association for Accessible Medicines.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation